Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Company Performance - Adaptive Biotechnologies (ADPT) has gained approximately 16.9% year-to-date, outperforming the Medical sector, which has returned an average of 2.2% [4] - The Zacks Consensus Estimate for ADPT's full-year earnings has increased by 9.6% over the past quarter, indicating improved analyst sentiment and a more positive earnings outlook [3] - Cardinal Health (CAH) is another Medical stock that has outperformed the sector with a year-to-date return of 21.7% [4] Industry Ranking - Adaptive Biotechnologies is part of the Medical - Biomedical and Genetics industry, which includes 504 companies and currently ranks 61 in the Zacks Industry Rank [6] - The Medical - Biomedical and Genetics industry has experienced an average loss of 5.3% year-to-date, highlighting ADPT's superior performance within its industry [6] - Cardinal Health operates in the Medical - Dental Supplies industry, which ranks 149 and has seen a year-to-date increase of 5.7% [7] Sector Overview - The Medical group, which includes Adaptive Biotechnologies, ranks 3 within the Zacks Sector Rank, indicating strong overall performance compared to other sectors [2] - The Zacks Rank system emphasizes earnings estimates and revisions, with Adaptive Biotechnologies currently holding a Zacks Rank of 2 (Buy) [3][5]